Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Calavo Growers Inc to Report Fiscal Quarter Results and Projected Growth

Elaine Mendonca by Elaine Mendonca
January 15, 2024
in Breaking News
0
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Calavo Growers, Inc. (CVGW) is set to unveil its financial results for the fiscal quarter ending in October 2023 on January 16, 2024, once the market closes. According to analysts, the projected earnings per share (EPS) for this quarter are $0.33, accompanied by a revenue of $271.68 million. Looking ahead, the company’s earnings are predicted to surge by a remarkable 134.38% in the upcoming year, soaring from $0.64 to $1.50 per share. Additionally, analysts expect a year-on-year revenue growth of 11.5%, reaching $271.7 million for this quarter. It is worth noting that the estimated quarterly EPS growth rate stands at -9.76%.

CVGW Stock Performance on January 15, 2024: Mixed Results and Potential Bearish Sentiment

CVGW Stock Performance on January 15, 2024:

CVGW stock exhibited mixed performance as it traded in the middle of its 52-week range and below its 200-day simple moving average. The stock closed at $28.35, experiencing a modest increase of $0.37 (1.32%) since the market last closed.

CVGW, or Calavo Growers Inc., is a company that specializes in the production and distribution of avocados and other fresh food products.

One important aspect to consider when evaluating a stock’s performance is its position relative to its 52-week range. CVGW’s stock trading in the middle of its 52-week range suggests that it has not experienced significant price fluctuations over the past year. This could indicate relative stability in the stock’s performance, which may be appealing to conservative investors seeking steady returns.

Furthermore, CVGW’s stock is currently trading below its 200-day simple moving average. The 200-day moving average is a commonly used technical indicator that helps identify the overall trend of a stock. When a stock is trading below its 200-day moving average, it may indicate a bearish sentiment or a potential downtrend. Investors and traders often monitor this indicator to gauge the stock’s long-term performance.

Looking at the price change on January 15, 2024, CVGW shares increased by $0.37 or 1.32% since the market last closed. This indicates a positive price momentum, suggesting that investors were optimistic about the stock’s potential. However, it is important to note that this increase occurred within a single trading day, and it may not necessarily reflect a long-term trend.

After the market closed, CVGW’s stock experienced a slight drop of $0.05 in after-hours trading. After-hours trading refers to the buying and selling of stocks that occurs outside of regular trading hours. This can be influenced by news releases, earnings reports, or other market events that take place after the closing bell. While the drop in after-hours trading may be seen as a negative sign, it is essential to consider the limited liquidity and lower trading volumes during this time.

In conclusion, CVGW’s stock performance on January 15, 2024, displayed mixed results. While the stock traded in the middle of its 52-week range, indicating relative stability, it remained below its 200-day simple moving average, potentially suggesting a bearish sentiment. The price change during regular trading hours showed a modest increase, but the subsequent drop in after-hours trading highlights the influence of post-market events. Investors should consider these factors and conduct further research before making any investment decisions related to CVGW stock.

CVGW Stock Performance on January 15, 2024: Promising Financials and Strong Start to the Year

CVGW Stock Performance on January 15, 2024: A Strong Start to the Year

On January 15, 2024, the stock performance of CVGW, or Calavo Growers, Inc., showcased a promising start to the year. Drawing data from CNN Money, we can analyze the financials of the company to understand the factors contributing to its positive stock performance.

One of the key indicators of a company’s success is its total revenue. In the past year, Calavo Growers recorded a total revenue of $1.19 billion, which marks an impressive increase of 12.81% compared to the previous year.

Furthermore, the total revenue for Calavo Growers in the third quarter amounted to $259.88 million, reflecting a 6.21% increase since the previous quarter.

Another significant aspect of a company’s financial performance is its net income. Calavo Growers reported a net income of -$6.25 million in the past year. However, this figure improved significantly in the third quarter, with a net income of $6.63 million, showcasing a remarkable increase of 265.86% compared to the previous quarter.

The earnings per share (EPS) is a crucial metric that investors often look at to assess a company’s profitability. Calavo Growers had an EPS of -$0.35 in the past year, but this figure experienced a substantial improvement in the third quarter, reaching $0.37.

Overall, the stock performance of CVGW on January 15, 2024, reflects the company’s strong financial performance. With a 12.81% increase in total revenue since last year and a significant improvement in net income and EPS, Calavo Growers is demonstrating its ability to navigate market challenges and deliver positive results. Investors can view this as a promising start to the year, indicating potential growth and profitability for the company in the future.

Tags: CVGW
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Fiscal (1)

PNC Financial Services Group Incs Upcoming Earnings Report and Market Expectations

Banking Markets and money

Hancock Whitneys Quarterly Earnings and Market Expectations

Finance_ Trading ratings today (2)

Anticipated Earnings Report and Market Impact for Guaranty Bancshares

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com